Header Logo

Connection

ADAM BROWN to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications ADAM BROWN has written about Antibodies, Monoclonal, Humanized.
ADAM BROWN
Connection Strength
0.012
Antibodies, Monoclonal, Humanized
  1. CD52 antigen may be a therapeutic target for eosinophilic rhinosinusitis. Ann Clin Lab Sci. 2007; 37(2):148-51.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.